Effect of rifampicin on anticoagulation of warfarin: A case report

BACKGROUNDThe drug interaction between warfarin and rifampicin is widely known, but there are still some difficulties in managing the combination of the two drugs. CASE SUMMARYA patient with brucellosis received strict monitoring from a Chinese pharmacist team during combination of warfarin and rifa...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of clinical cases Vol. 9; no. 5; pp. 1087 - 1095
Main Authors Hu, Ya-Ni, Zhou, Bo-Ting, Yang, Hua-Rong, Peng, Qi-Lin, Gu, Xu-Rui, Sun, Shu-Sen
Format Report
LanguageEnglish
Published 16.02.2021
Online AccessGet full text

Cover

More Information
Summary:BACKGROUNDThe drug interaction between warfarin and rifampicin is widely known, but there are still some difficulties in managing the combination of the two drugs. CASE SUMMARYA patient with brucellosis received strict monitoring from a Chinese pharmacist team during combination of warfarin and rifampicin. The dose of warfarin was increased to 350% in 3 mo before reaching the lower international normalized ratio treatment window. No obvious adverse reaction occurred during the drug-adjustment period. This is the first case report of long-term combined use of rifampicin and warfarin in patients with brucellosis and valve replacement in China based on the Chinese lower warfarin dose and international normalized ratio range. CONCLUSIONAnticoagulation for valve replacement in Chinese patients differs from that in other races. Establishment of a pharmacist clinic provides vital assistance in warfarin dose adjustment.
Bibliography:ObjectType-Case Study-2
content type line 59
SourceType-Reports-1
ObjectType-Report-1
ISSN:2307-8960
2307-8960
DOI:10.12998/wjcc.v9.i5.1087